Dna Methylation Markers As Predictors Of Initiation And Progression Of Gastric Carcinomas

Z. J. Liu,Y. H. Gao,J. Zhang,Lirong Pei,Y. Qin,J. F. Ji,H. Shi,D. Deng
2011-01-01
Abstract:To explore DNA methylation differences between gastric carcinoma (GC) and its corresponding cutting edge (CE) tissues, with or without metastasis, we compared the DNA methylome of 8 GC patients using both a customized Agilent Promoter Array and RLGS assays. Aberrant methylation of 547 cancer-related and 602 metastasis-related genes was identified. The methylation status of 63 candidate loci identified through the methylation array analysis, along with 8 known genes, were further analyzed using denatured-HPLC in GC and CE samples from GC patients (N=48 or 102). Aberrant methylation of CpG islands in 11 genes (BMP3, BNIP3, GFRA1, HOXD10, KCNH1, PSMD10, p16, PTPRT, SRF, TFPI2, and ZNF382) was confirmed in GC tissues (P<0.05). GFRA1, SRF, and ZNF382 methylation was significantly correlated with GC metastasis.
What problem does this paper attempt to address?